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A technique has been developed to investigate [3H]sulpiride binding in rat brain sections using quan- 
titative autoradiography and tritium-sensitive film. Binding was saturable and reversible with very low 
nonspecific binding. [3H]Sulpiride bound  to an apparent single population of sites in striatum with a Kd 
of  3.2 nM and  Bmax of  447 fmo l / mg  protein. Binding sites were localized in the lamina glomerulosa of  the 
olfactory bulb, nucleus accumbens,  olfactory tubercle, s tr iatum and substantia nigra. 
Sulpiride is a substituted benzamide compound used widely in Europe as an anti- 
psychotic drug [5, 10] which produces less extrapyramidal disturbances than other 
neuroleptics [14]. Sulpiride is considered to be an atypical neuroleptic drug since it 
possesses properties both similar to and different from the 'classical neuroleptics' 
such as phenothiazine, butyrophenone and thioxanthine antipsychotic drugs. Like 
the classical neuroleptics, sulpiride is a potent antiemetic drug [5]; it increases pro- 
lactin secretion [9] and selectively increases striatal and mesolimbic dopamine syn- 
thesis and tyrosine hydroxylase activity [11, 16]. Sulpiride, however, is less potent 
than the classical neuroleptic drugs when competing for striatal binding sites [4, 8], 
at blocking amphetamine- or apomorphine-induced hyperactivity, antagonizing 
apomorphine-induced stereotypies [12] and producing a cataleptic response [7]. 
Since sulpiride does not inhibit dopamine-stimulated adenylate cyclase activity [2, 
19] and blocks the inhibiting action of dopamine on prolactin release from the 
pituitary, it has been proposed to be a selective D2 antagonist [6], making it a 
valuable tool for investigations of dopaminergic systems. 
Specific binding of [3H]sulpiride to striatal membranes has been demonstrated us- 
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ing filtration and centrifugation techniques [17, 20]. We report here the use of  quan- 
titative autoradiography to study the kinetic and saturation characteristics as well 
as the regional distribution of  [3H]sulpiride binding sites in rat brain. 
The quantitative autoradiographic receptor binding technique used was similar to 
that described previously [13]. Male Sprague-Dawley rats (Charles River, Wilm- 
ington, MA; Strain Crl: CD(SD)BR), 150-175 g, were decapitated and their brains 
were quickly removed, blocked, mounted on a microtome chuck with Lipshaw 
embedding matrix and frozen under powdered dry ice. Twenty micrometer coronal 
brain sections were cut on a Harris cryostat and thaw-mounted onto gelatin-coated 
slides. 
Sections were washed two times for 5 min in ice-cold 50 mM Tris-HCl (pH 7.7 
at 4°C). For saturation studies, sections were incubated for 60 min at 22°C with 
various concentrations (0.1-40 nM) of [3H](-)-sulpiride (72 Ci/mmol;  New 
England Nuclear, Boston, MA) in 50 mM Tris-HC1 (pH 7.7) containing 120 mM 
NaCI. Due to rostral-to-caudal variations in receptor density, specific binding for 
each concentration of tritiated ligand was determined four times at 280 ~m intervals, 
and the average amount bound in these sections was taken as the representative 
amount bound for Scatchard analysis. In regional distribution investigations, sec- 
tions were incubated for 60 min with a concentration of 10 nM [3H]sulpiride. For 
kinetic studies, sections were incubated with 5 nM [3H]sulpiride for 0-60 min. 
Nonspecific binding was determined in the presence of  1/zM unlabeled ( +_ )-sulpiride 
(Delagrange International Paris, France) or 1 #M (+)-butaclamol (Ayerst Labs., 
Montreal, Canada). After incubation, sections were rinsed two times for 5 min in 
ice-cold 50 mM Tris-HCl (pH 7.7 at 4°C). For dissociation studies sections received 
the two standard buffer rinses followed by immersion in a large volume ('infinite 
dilution') of incubation buffer at 22°C for 0-60 min. Slides were blown dry with 
warm air, placed in x-ray cassettes with radioactive standards prepared as described 
elsewhere [131 and apposed to Ultrofilm [3H](LKB). After a 30-day exposure at 
4°C, the film was developed in Kodak D-19 for 4 min at 21°C, fixed and dried. The 
film was placed in a photographic enlarger and the optical densities of areas of the 
film were determined with a computer-assisted microdensitometer [1]. Forty 
readings were averaged from the striatal sections per tritiated ligand concentration 
and radioactivity per #g protein was determined by a regression analysis which com- 
pared film densities produced by the sections with those produced by the standards 
[13]. 
Optimal binding with this method was obtained under conditions in which sodium 
ions were included in the incubation buffer which is consistent with previous studies 
[18]. Blockade of  [3H]sulpiride binding by butaclamol was stereospecific; 1 #M ( + )- 
butaclamol displaced 85O7o of  the total binding of 30 nM [3H]sulpiride while ( - ) -  
butaclamol had no detectable effect on the total binding. Specific binding of 
[3H]sulpiride to brain slices represented 85-9007o of total binding which compares 
favorably to that obtained using membrane preparations, 3907o [17] and 80o7o [21], 
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and synaptic membrane  preparations,  55% [20]. Regional distribution studies show- 
ed restricted localization of [3H]sulpiride binding to dopaminergic areas. Specific 
[3H]sulpiride binding was limited to the lamina glomerulosa of  the olfactory bulb, 
caudate-putamen,  nucleus accumbens, olfactory tubercle and substantia nigra (Fig. 
A 
~¢,f,, 
Fig. 1. Autoradiographs of [3H]sulpiride binding. A: total binding in caudate-putamen (CP), nucleus ac- 
curnbens (NA) and olfactory tubercle (OT). B: nonspecific binding of adjacent section as defined by the 
presence of 1 /~M unlabeled sulpiride. [~H]sulpiride concentration was 14.3 nM. 
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1). The highest density of  binding was in the striatum and the lowest in the substan- 
tia nigra. No binding was detectable in non-dopaminergic areas such as the thalamus 
and cerebellum (Table I). 
Binding of [3H]sulpiride to brain slices was saturable and reached equilibrium by 
30 min. The binding remained at equilibrium for at least 90 min. Scatchard analysis 
of  [3H]sulpiride binding sites in the caudate revealed an apparent single 
homogeneous population of  binding sites with a Kd of 3.2_+ 0.4 nM and a Bmax of  
447__+ 14.0 fmol /mg protein, n = 7  (Fig. 2A). Hill coefficients were not different 
from 1 suggesting an apparent single set of  binding sites. Association studies reveal- 
ed an association rate constant (K0 of  5.5 _+ 0.02 × 10 7 M - 1 .  min-1, n = 3. Dissocia- 
tion studies revealed a dissociation rate constant (K_ ~) of  0.15 _+ 0.04 min - ~, n -- 3. 
Both association and dissociation curves were monophasic suggesting a single set of  
sites (Fig. 2B). The estimated Ka value calculated from the ratio K_ ~/K~ was 2.6 
nM which was in good agreement with our Ka value of  3.2 nM determined from 
equilibrium saturation studies. 
This report demonstrates that kinetic, saturation and regional distribution data 
on [3H]sulpiride binding can be obtained using quantitative autoradiographic 
techniques. The half time of dissociation of [3H]sulpiride from striatal binding sites 
was 5 min at 22°C which is consistant with a t,/2 of  4 min at 25°C reported for a 
membrane preparation filter binding technique [21]. [3H]Sulpiride binds to the 
brain sections in a specific, saturable and reversible manner with a Kd of 3.2 nM 
and a Bmax of 447 fmol/mg protein which is consistent with those described by 
others: Kd=7.4  nM, Bmax=240 fmol /mg protein [20]; Ka=5 .6  nM, Bma~=640 
fmol /mg protein [21]. Our data suggest that [3H]sulpiride binds to a single high- 
affinity site. The possibility that a low-affinity site may appear at higher ligand con- 
centrations than those used in this study is currently under investigation. 
The [3H]sulpiride binding sites are selectively located in the lamina glomerulosa 
TABLE I 
REGIONAL DENSITY OF [3H]SULPIRIDE BINDING SITES 
Relative density of [3H]sulpiride binding sites in various brain regions was determined using a spot den- 
sitometer as described in text. Sections taken every 200 tzm throughout the brain were incubated with 10 
nM [~H]sulpiride in the presence and absence of  1 t~M sulpiride to define specific binding. Values 
reported are the average values taken from two brains which varied less than 10°70. 
Region Specific binding (fmol/mg protein) 
Lamina glomerulosa 111 
Striatum 297 
Nucleus accumbens 224 
Olfactory tubercle 170 
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Fig. 2. A: a representative Scatchard plot of [3H]sulpiride binding in striatum (Bronx = 423 fmol/mg pro- 
tein, r=0.98) .  Ligand concentrations between 0.5 and 40 nM were used in this experiment. 
Autoradiography was performed as described in text. Each point represents specific binding (the average 
of  40 readings in the striatum minus readings from adjacent sections incubated in presence of 1 #M 
sulpiride). The experiment has been replicated 7 times. B: a representative association and dissociation 
plot of [3H]sulpiride binding in striatum. The concentration of  [3H]sulpiride was 6 nM. Points represent 
specific binding. Tissue was incubated 0-60 min for association studies (circles), and additional sections 
were rinsed as described in text for dissociation studies (squares). The experiment has been replicated 3 
times. 
of the olfactory bulb, caudate putamen, nucleus accumbens, olfactory tubercle and 
substantia nigra. This regional distribution contrasts with the regional distribution 
of [3H]spiroperidol binding sites as demonstrated by similar in vitro 
autoradiographic techniques [15], which include hippocampus and amygdala in ad- 
dition to those areas labeled by [3H]sulpiride in our study. As both sulpiride and 
low concentrations of spiroperidol are considered specific ligands for the D2 recep- 
tor, the discrepancies seen in the regional distribution may suggest that sulpiride 
labels a subpopulation of D2 or spiroperidol receptor sites. Alternatively 
[3H]sulpiride may be the more selective D2 ligand while the [3H]spiroperidol binding 
in the hippocampus and amygdala may be due to interaction with non-D2 sites for 
which [3H]sulpiride has low affinity. This possibility is supported by the work of 
Zahnisher and Dubocovich who demonstrated two classes of sites for 
[3H]spiroperidol, one of which was identical to the single site they demonstrated for 
[3H]sulpiride [21]. It is also possible that there are regions of low-density sulpiride 
binding sites in the brain not detected at our present film exposure period. Longer 
film exposure periods are being examined. 
It is of interest to rote that the restricted distribution pattern of these receptors 
in caudate-putamen, nucleus accumbens and olfactory tubercle resembles the 
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ace ty lchol ines te rase  posi t ive  s ta ining in these same areas ,  which has been cited by 
He imer  as one piece o f  evidence suppor t ing  his ventra l  s t r ia ta l  concept  [3]. He imer  
a na tomica l l y  def ines  the o l f ac to ry  tuberc le  and  nucleus accumbens  'ven t ra l  
s t r i a t um ' .  He  suggests,  based on  embryo log ica l ,  cy to logica l ,  h i s tochemica l  and  
hodo log ica l  evidence tha t  the o l f ac to ry  tuberc le  and  nucleus accumbens  are  func- 
t iona l ly  re la ted  s t r ia ta l  s t ructures  which p rov ide  a means  by which c o m p o n e n t s  o f  
the  l imbic  system m a y  inf luence the s t r ia tum.  The  high densi ty  o f  [3H]sulpir ide 
b ind ing  sites in nucleus accumbens ,  o l f ac to ry  tuberc le  and c a u d a t e - p u t a m e n  sug- 
gests a re la t ionship  be tween  these s t ructures .  [3H]Sulpir ide b ind ing  m a y  prove  to be 
a useful  h i s tochemica l  tool  in examin ing  the ana tomic a l  re la t ionships  o f  the s t r ia tal  
system.  
We have d e m o n s t r a t e d  tha t  sa tu ra t ion ,  kinetic  and  regional  d i s t r ibu t ion  da t a  on 
[3H]sulpir ide b ind ing  sites m a y  be ob ta ined  using quan t i t a t ive  a u t o r a d i o g r a p h i c  
techniques .  The  use o f  [3H]sulpir ide with this technique  has the  advan tage  o f  very 
low nonspeci f ic  b ind ing  even at  high l igand concen t ra t ions  (85% specific b inding  
at 40 nM).  In add i t i on  it a l lows for  the e x a m i n a t i o n  o f  b ind ing  sites in highly cir- 
cumscr ibed  regions o f  the bra in .  
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